Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa

Journal of Applied Microbiology

Volumn 101, Issue 6, 2006, Pages 1367-1379

  Pavlov, D N ^a   Van Zyl, W B ^a   Van Heerden, J ^a   Kruger, M ^b   Blignaut, L ^b   Grabow, W O K ^a   Ehlers, M M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

5 untranslated region; Immunocompetent; Immunodeficient children; Oral poliovirus vaccine; Sequencing; Vaccine derived polioviruses; VP1 region

Indexed keywords

DISEASE CONTROL; DISEASES; POLYMERASE CHAIN REACTION; VIRUSES;

5′-UNTRANSLATED REGIONS; CLASSIFIEDS; IMMUNOCOMPETENT; IMMUNODEFICIENT CHILD; ORAL POLIOVIRUS VACCINE; POLIO VIRUS; SEQUENCING; VACCINE DERIVED POLIOVIRUSES; VACCINE STRAINS; VP1 REGION;

VACCINES;

CAPSID PROTEIN; RESTRICTION ENDONUCLEASE;

HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; IMMUNOCOMPETENCE; POLIOMYELITIS; POLYMERASE CHAIN REACTION; VACCINE; VIRUS;

5' UNTRANSLATED REGION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; CONTROLLED STUDY; ENTEROVIRUS; FECES; FECES ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; INFANT; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLIOMYELITIS VIRUS; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH AFRICA; VIRUS DETECTION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

AFRICA; SOUTH AFRICA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

ENTEROVIRUS; MIRIDAE; POLIOVIRUS;

EID: 33750827861     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2006.03020.x     Document Type: Article

References (50)

1. Bellmunt, A., May, G., Zell, R., Pring-Akerblom, P., Verhagen, W. and Heim, A. (1999) Evolution of poliovirus Type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265, 178-184.
2. Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A.R., Vivarelli, R. et al. (2003) Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol 84, 1215-1221.
3. Centers for Disease Control and Prevention (2001) Circulation of a type 2 vaccine-derived poliovirus - Egypt, 1982-1993. Morb Mortal Wkly Rep 50, 41-51.
4. Centers for Disease Control and Prevention (2003) Progress toward poliomyelitis eradication - Southern Africa, 2001 - March 2003. Morb Mortal Wkly Rep 52, 521-524.
5. Chezzi, C. (1996) Rapid diagnosis of poliovirus infection by PCR amplification. J Clin Microbiol 34, 1722-1725.
6. Chitsike, I. and van Furth, R. (1999) Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in a child with HIV infection in Zimbabwe: case report. Br Med J 318, 841-843.
7. Divizia, M., Palombi, L., Buonomo, E., Donia, D., Ruscio, V., Equestre, M., Leno, L., Pana, A. et al. (1999) Genomic characterisation of human and environmental polioviruses isolated in Albania. Appl Environ Microbiol 65, 3534-3539.
8. Dowdle, W.R., De Gourville, E., Kew, O.M., Pallansch, M.A. and Wood, D.J. (2003) Polio eradication: the OPV paradox. Rev Med Virol 13, 277-291.
9. Equestre, M., Genovese, D., Cavalieri, F., Fiore, L., Santoro, R. and Bercoff, R.P. (1991) Identification of a consistent pattern of mutations in neurovirulent variants derived from the Sabin vaccine strain of poliovirus type 2. J Virol 65, 2707-2710.
10. Felsenstein, J. (1981) Evolution trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17, 368-376.
11. Fine, P.E. and Carneiro, I.A.M. (1999) Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 150, 1001-1021.
12. Gavrilin, G.V., Cherkasova, E.A., Lipskaya, G.Y., Kew, O.M. and Agol, V.I. (2000) Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74, 7381-7390.
13. Georgescu, M.M., Balanant, J., Macadam, A., Otelea, D., Combiescu, M., Combiescu, A.A., Crainic, R. and Delpeyroux, F. (1997) Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol 71, 7758-7768.
14. Gow, J.W., Behan, W.M.H., Clements, G.B., Woodall, C., Riding, M. and Behan, P.O. (1991) Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br Med J 302, 692-696.
15. Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F. et al. (2000) Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74, 8434-8443.
16. Haisey, N.A., Pinto, J., Espinosa-Rosaies, F., Faure-Fontenla, M.A., da Silva, E., Khan, A.J., Webster, A.D.B., Minor, P. et al. (2004) Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil and the United Kingdom. Bull World Health Organ 82, 16-23.
17. Higgins, D.G. and Sharp, P.M. (1988) Clustal: a package for performing multiple sequence alignment on a microcomputer. Genetics 73, 237-244.
18. Hovi, T., Lindholm, N., Savolainen, C., Stenvik, M. and Burns, C. (2004) Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months. J Gen Virol 85, 369-377.
19. Hughes, P.J., Evans, D.M., Minor, P.D., Schild, G.C., Almond, J.W. and Stanway, G. (1986) The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland. J Gen Virol 67, 2093-2102.
20. Ion-Neldescu, N., Dobrescu, A., Strebel, P.M. and Sutter, R.W. (1994) Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet 343, 51-52.
21. Kämmerer, U., Kunkel, B. and Korn, K. (1994) Nested polymerase chain reaction for specific detection of and rapid identification of human picornaviruses. J Clin Microbiol 32, 285-291.
22. Kew, O.M., Sutter, R.W., Nottay, B.K., MacDonough, M.J., Prevots, D.R., Quick, L. and Pallansch, M.A. (1998) Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 36, 2893-2899.
23. Kew, O.M., Morris-Glasgow, V., Landaverde, M. and 21 other authors (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356-359.
24. Kew, O.M., Wright, P.F., Agol, V.I., Delpeyroux, F., Shimizu, H., Nathanson, N. and Pallansch, M.A. (2004) Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82, 16-23.
25. Kuan, M.M. (1997) Detection and rapid differentiation of human enteroviruses following genomic amplification. J Clin Microbiol 35, 2598-2601.
26. Li, J., Zhang, L.B., Yoneyama, T., Yoshida, H., Shimizu, H., Yoshii, K., Hara, M., Nomura, T. et al. (1996) Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Arch Virol 141, 1047-1054.
27. Liu, H.M., Zheng, D.P., Zhang, L.B., Oberste, M.S., Kew, O.M. and Pallansch, M.A. (2003) Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol 77, 10994-11005.
28. Macadam, A.J., Pollard, S.R., Ferguson, G., Skuce, R., Wood, D., Almond, J.W. and Minor, P.D. (1993) Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192, 18-26.
29. Martin, J. and Minor, P.D. (2002) Characterisation of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. J Virol 76, 5339-5349.
30. Martin, J., Dunn, G., Hull, R., Patel, V. and Minor, P.D. (2000a) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74, 3001-3010.
31. Martin, J., Ferguson, G.L., Wood, D.J. and Minor, P.D. (2000b) The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland. Virology 278, 42-49.
32. Martin, J., Samoilovich, E., Dunn, G., Lackenby, A., Feldman, E., Heath, A., Svirchevskaya, E., Cooper, G., Yermalovich, M. and Minor, P.D. (2002) Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76, 10921-10928.
33. Minor, P.D. (1992) The molecular biology of poliovaccines. J Gen Virol 73, 3065-3077.
34. Minor, P.D. (1999) Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis. Expert Rev Mol Med. http://www-ermm.cbcu.cam.ac.uk.
35. Minor, P.D. and Dunn, G. (1988) The effect of sequences in the 5′;non-coding region on the replication of polioviruses in the human gut. J Gen Virol 69, 1091-1096.
36. Minor, P.D., Dunn, G., Ramsay, M.E. and Brown, D. (2005) Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains. J Med Virol 75, 153-160.
37. Nathanson, N. and Fine, P. (2002) Poliomyelitis eradication - a dangerous endgame. Science 296, 269-270.
38. Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P. and Delpeyroux, F. (2003) Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9, 885-887.
39. Sabin, A.B. (1957) Properties and behaviour of orally administered attenuated poliovirus vaccine. J Am Microbiol Assoc 164, 1216-1223.
40. Sutter, R.W. and Prevots, D.R. (1994) Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 11, 426-438.
41. Sutter, R.W., Kew, O.M. and Cochi, S.L. (2003) Poliovirus vaccine - live. In Vaccines, 4th edn ed. Plotkin, S.A. and Orenstein, W.A. pp. 651-705. Philadelphia, PA: WB Saunders.
42. Tatem, J.M., Weeks-Levy, C., Georgiu, A., DiMichele, S.J., Gorgacz, E.J., Racaniello, V.R., Cano, F.R. and Mento, S.J. (1992) A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol 66, 3194-3197.
43. Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis (2002) 'Endgame' issues for the global polio eradication initiative. Clin Infect Dis 34, 72-77.
44. Triki, H., Barbouche, M.R., Bahri, O., Bejaoui, M. and Dellagi, K. (2003) Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol 41, 1203-1211.
45. Wood, N. and Thorley, B. (2003) Viewpoint. Towards global poliomyelitis eradication: the successes and challenges for a developed country. J Paediatr Child Health 39, 647-650.
46. Wood, D.J., Sutter, R.W. and Dowdle, W.R. (2000) Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ 78, 347-357.
47. World Health Organization (2004) Manual for the Virological Investigation of Poliomyelitis. Geneva, Switzerland: World Health Organization (WHO/EPI/GEN/04).
48. Yang, C.-F., De, L., Holloway, B.P., Pallansch, M.A. and Kew, O.M. (1991) Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res 20, 159-179.
49. Yang, C.-F., De, L., Yang, S.-J., Gòmez, J.R., Cruz, J.R., Holloway, B.P., Pallansch, M.A. and Kew, O.M. (1992) Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res 24, 277-296.
50. Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H. et al. (2003) Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983-1993. J Virol 77, 8366-8377.